Remimazolam and Propofol Anesthesia in Elderly Patients
Not yet recruiting
Ajou University School of Medicine
N/A
2022-02-01
Remimazolam is a recently developed ultra-short agonist acting at the benzodiazepine binding
site of the gamma-aminobutyric acid (GABA)A receptor. Remimazolam has a combination of the
hemodynamic stability of benzodiazepines and the advantages of propofol, such as rapid onset,
short duration of action, and improved controllability.
A recent study showed that the efficacy of two induction doses of remimazolam (6 and 12
mg/kg/h) as a sedative for general anesthesia was not inferior to propofol (2.0-2.5 mg/kg),
and hemodynamically more stable. On the other hand, a study on the emergence time and quality
between propofol and remimazolam showed inconsistent results.
The purpose of this study is to compare remimazolam to propofol on the intraoperative
hemodynamic changes and recovery profiles, when used in combination with remifentanil in
elderly patients undergoing general anesthesia.
Remimazolam and Propofol on the Left Ventricular Strain During Anesthesia Induction for Non-cardiac Surgery
Not yet recruiting
Konkuk University Medical Center
Phase 4
2022-08-01
This study to compare the impacts of remimazolam or propofol on the left ventricular global
longitudinal strain (LV-GLS) during anesthesia induction for non-cardiac surgery.
LV-GLS is analyzed by using speckle tracking technique of transthoracic echocardiography.
Total Intravenous Anesthesia for Rigid Bronchoscopy Using Remimazolam
Not yet recruiting
Samsung Medical Center
N/A
2023-05-01
Rigid bronchoscopy usually requires deep general anesthesia, but the duration of the
procedure is relatively short. Remimazolam, a recently developed anesthetics, showed faster
recovery from anesthesia and stable hemodynamics compared to propofol, the most popular
anesthetics. However, few studies have investigated the usefulness of remimazolam for rigid
bronchoscopy. Therefore, the investigators compared the usefulness of propofol and
remimazolam in total intravenous anesthesia for rigid bronchoscopy.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
